(Q43820683)

English

Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients

scientific article published on 4 December 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

0 references

Geneviève Chêne

2

object named as

Geneviève Chêne

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Vincent Le Moing

1

object named as

Vincent Le Moing

0 references

Catherine Leport

3

object named as

Catherine Leport

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

François Raffi

9

object named as

François Raffi

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Charlotte Lewden

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ségolène Duran

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Michel Garré

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bernard Masquelier

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Michel Dupon

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Antiprotéases Cohorte (APROCO) Study Group

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

4 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

239-247

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Virologic and regimen termination surrogate end points in AIDS clinical trials

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Virological response to protease inhibitor therapy in an HIV clinic cohort.

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Distinguishing efficacy, individual effectiveness and population effectiveness of therapies

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Antiviral effect of double and triple drug combinations amongst HIV-infected adults

1 reference

https://api.crossref.org/works/10.1086%2F324354

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43820683&oldid=2103643643"